Instalab
logoInstalab

Protein

24 Hour Urine Test
The reference standard for measuring how much protein your kidneys are leaking, when an exact answer matters.
4.9 (4,728 reviews)
Tested by Quest or Access Medical
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Self-collect at home
Kit shipped to you or available for pickup at nearby lab
Get results
Explained with clear next steps, no medical jargon

Should you take a Protein test?

This test is most useful if any of these apply to you.

Already Managing Kidney Issues
This test gives the most precise count of how much protein your kidneys are losing, a strong predictor of how kidney disease will progress.
Pregnant With High Blood Pressure
This is the reference test for confirming significant proteinuria when preeclampsia is suspected, especially with chronic hypertension or diabetes.
Living With Lupus or Autoimmune Disease
This test tracks kidney involvement in conditions like lupus nephritis, where the trajectory over time guides treatment intensity and response.
Watching for Diabetic Kidney Disease
This test confirms and quantifies protein loss when screening flags a problem, helping decide when to start kidney-protective medications.

About Protein

If your kidneys are working properly, very little protein should make it into your urine. When proteins do start appearing in larger amounts, it usually means the filtering system inside your kidneys is leaking, the reabsorbing system in the tubules is failing, or your bloodstream is carrying abnormal proteins your kidneys cannot keep up with. A 24-hour urine protein collection captures every drop of urine you produce in a full day and measures the total protein excreted, giving the most complete picture of what your kidneys are losing.

This test is the long-standing reference standard for quantifying proteinuria (protein in the urine). It is the measurement other urine protein tests are compared against, and it remains the most precise way to confirm how much protein is being lost, especially when smaller spot urine tests give borderline or inconsistent results.

What This Test Actually Measures

The 24-hour urine protein is not one molecule. It is the combined mass of many different proteins your kidneys filter out over a full day. In healthy kidneys, the filter is nearly watertight to large blood proteins, and what little does get through is reabsorbed by the tubules. When protein excretion rises above typical levels, the pattern of proteins helps localize the problem: glomerular leak (loss of filter selectivity, usually rich in albumin), tubular leak (failure to reabsorb small proteins), or overflow (too much abnormal protein in the blood, such as immunoglobulin light chains).

Because the measurement captures every void over 24 hours, it smooths out the natural variation in how much protein you spill at different times of day. That is its main advantage over a single spot urine sample, but it is also why collection errors are the most common cause of misleading results.

Chronic Kidney Disease and Progression

Detecting protein in the urine is one of the earliest signals of chronic kidney disease (CKD). The presence of proteinuria identifies people at high risk of CKD progression, the need for dialysis, and premature cardiovascular death. The amount of protein loss is one of the strongest available predictors of how quickly kidney function declines, which is why nephrologists rely on it to set treatment intensity.

Clinically, higher categories of daily protein excretion correspond to increasing risk: small amounts are considered normal to mildly increased, larger amounts moderately increased, and very high amounts severely increased. Excretion in the nephrotic range, on the order of several grams per day, strongly suggests significant glomerular disease.

Glomerular Diseases

In glomerular diseases like IgA nephropathy, membranous nephropathy, focal segmental glomerulosclerosis, and minimal change disease, even small differences in protein loss can change prognosis and immunotherapy decisions. The 24-hour collection is favored over spot ratios here because precision matters: spot protein-to-creatinine ratios correlate well with 24-hour results in IgA nephropathy but perform poorly in membranous nephropathy and nephrotic syndromes, where readings can disagree substantially. That said, KDOQI commentary acknowledges that trending spot ratios in an individual patient over time can still be clinically informative once a baseline has been established.

Lupus Nephritis

In lupus nephritis (kidney inflammation from systemic lupus), the trajectory of 24-hour urine protein over months separates patients into clear response groups. In a real-world cohort of 811 patients, four trajectories emerged: rapid responders reached complete kidney remission about 84% of the time, while non-responders did so only about 10% of the time. A single reading cannot tell you which trajectory you are on. Serial measurements can.

Hypertension During Pregnancy

In pregnancy, a 24-hour urine collection remains the diagnostic reference for evaluating suspected preeclampsia. It is especially valuable for women entering pregnancy with chronic hypertension, diabetes, autoimmune disease, or kidney disease, because a baseline protein measurement makes it easier to detect a meaningful rise later. Spot protein-to-creatinine ratios are useful as a rule-out test, with pooled sensitivity and specificity around 91% and 89% in a meta-analysis of 28 studies. Several guidelines and expert reviews now consider spot PCR adequate for many clinical decisions in hypertensive pregnant women, with the 24-hour test reserved for cases where the spot result is borderline or inconsistent.

AL Amyloidosis and Plasma Cell Disorders

In systemic AL amyloidosis, abnormal immunoglobulin light chains produced by a clonal plasma cell population misfold, deposit in the kidneys, and cause heavy protein loss. Renal involvement in this disease is defined by substantial daily protein excretion, predominantly albumin. Substituting a spot ratio for the 24-hour collection in this population would change kidney staging or organ response category in 10% to 20% of patients, which is why the 24-hour test is preferred when the answer drives therapy.

How 24-Hour Protein Compares to Other Urine Tests

There are three other urine protein measurements you may have seen, each answering a slightly different question. The 24-hour collection is the most thorough but also the most cumbersome.

TestWhat It MeasuresBest Use
24-hour urine proteinTotal daily protein loss, all typesPrecise quantification, glomerular disease, lupus nephritis, AL amyloidosis, pregnancy confirmation
Spot PCR (protein-to-creatinine ratio)Snapshot of total protein, adjusted for urine concentrationScreening, routine follow-up in non-nephrotic ranges
Spot ACR (albumin-to-creatinine ratio)Snapshot of albumin only, adjusted for urine concentrationPreferred for CKD screening and staging, diabetic kidney disease
Urine dipstickRough presence of protein, semi-quantitativeInitial screen only, high false-positive rate

What this means for you: a normal dipstick or chemistry panel does not rule out clinically meaningful protein loss. Albumin and total protein can also tell different stories. In one study of adults with congenital heart disease, 79% of patients with elevated 24-hour total protein still had normal-to-mild albumin levels, and only the total protein measurement predicted worse outcomes.

Why a Single Reading Can Fool You

A 24-hour urine collection is only as accurate as the collection itself. Up to 20% of collections are incomplete or over-collected, and this is the dominant source of error. The result hinges on capturing every void in the window, refrigerating the container, and timing the start and stop correctly. Even with perfect collection, several other factors can distort interpretation.

  • Incomplete or excess collection: missed voids underestimate true protein loss, while including a void from outside the 24-hour window inflates it. Urine creatinine in the same sample helps assess whether the collection was complete.
  • Recent intense exercise: vigorous exertion can transiently increase protein excretion. Avoid heavy exercise in the 24 hours before and during collection.
  • Acute illness, fever, or dehydration: these can temporarily raise protein excretion or concentrate the sample, leading to results that do not reflect your baseline.
  • Orthostatic proteinuria: in some people, especially adolescents and children, protein appears only when upright. This is benign but can flag a false alarm on a standard 24-hour collection.

Some medications shift the number without causing kidney disease, and others genuinely change kidney handling of protein. If you are on corticosteroids, recently received contrast dye, or are mid-course of NSAIDs, the result may be temporarily skewed. Discuss your full medication list with the clinician interpreting the result.

Why One Reading Is Not Enough

Protein excretion varies day to day, and a single 24-hour result is a snapshot, not a verdict. The most useful information comes from a trend: a baseline value, a repeat in 3 to 6 months if you are starting treatment or making lifestyle changes, and at least annual monitoring once you know where you stand. In lupus nephritis, in IgA nephropathy, and after starting renin-angiotensin blockade or SGLT2-class drugs, the slope of change over months is what tells you whether the intervention is working.

If your first reading is borderline or inconsistent with a spot test, repeat it before drawing conclusions. Albuminuria in particular has high within-person variability, so two or three serial samples are often advised before making major decisions.

What to Do If Your Result Is Out of Range

An elevated 24-hour urine protein is a finding that demands a workup, not a diagnosis on its own. The pattern of proteins, kidney function, blood pressure, and clinical context all shape what comes next.

  • Confirm the result: repeat the 24-hour collection or pair it with a spot protein-to-creatinine ratio and an albumin-to-creatinine ratio to localize the problem.
  • Check companion tests: eGFR, cystatin C, serum creatinine, electrolytes, and urinalysis with microscopy together describe overall kidney status. A comprehensive metabolic panel and lipid panel add cardiovascular context.
  • Look for an underlying driver: evaluate blood pressure, blood glucose, HbA1c, autoimmune markers (ANA, complement), and serum/urine protein electrophoresis if a plasma cell disorder is plausible.
  • Consider a specialist referral: persistently heavy protein loss, any nephrotic-range value, rising trajectory, or abnormal eGFR usually warrants nephrology evaluation. AL amyloidosis suspicion belongs with a hematologist.

The decision pathway depends on combinations of findings, not on any single number. Heavy protein loss with normal kidney function may still indicate early glomerular disease. Modest protein loss with declining eGFR is a different signal entirely.

What This Test Cannot Tell You

The amount of protein lost is not a direct measure of how severe the underlying disease is in every situation. In preeclampsia, blood pressure and end-organ damage matter more for maternal and neonatal outcomes than the absolute protein number, and repeated quantification once preeclampsia is diagnosed does not improve outcomes. In CKD, two patients with the same daily protein loss can have very different prognoses depending on kidney function, blood pressure, and disease type. Use the number as one input in a larger picture, not the whole story.

What Moves This Biomarker

Evidence-backed interventions that affect your Protein level

↓ Decrease
ACE inhibitors or angiotensin receptor blockers (ARBs)
These blood pressure medications lower urine protein excretion through a blood-pressure-independent effect on the kidney filter, making them first-line therapy when proteinuria is present. They are the cornerstone of treatment for proteinuric kidney disease and have been shown to reduce protein loss across CKD, diabetic kidney disease, and many glomerular conditions.
MedicationStrong Evidence
↓ Decrease
SGLT2 inhibitors (dapagliflozin, empagliflozin, canagliflozin)
This class of diabetes medications lowers urinary albumin and protein excretion and slows progression of kidney disease. Across dedicated kidney outcome trials (CREDENCE, DAPA-CKD, EMPA-KIDNEY), SGLT2 inhibitors reduced albuminuria by roughly 21% to 35% and cut the risk of kidney failure, sustained eGFR decline, and cardiovascular death in patients with CKD, with or without diabetes.
MedicationStrong Evidence
↑ Increase
VEGFR-targeted tyrosine kinase inhibitors (lenvatinib, sorafenib, others)
These cancer therapies for renal cell carcinoma, hepatocellular carcinoma, and thyroid cancer cause real kidney damage that shows up as proteinuria. Across studies, 6% to 34% of treated patients develop proteinuria of any grade, and 1% to 10% develop grade 3 or higher, sometimes requiring treatment discontinuation. This is genuine drug-induced kidney injury, not a measurement artifact.
MedicationStrong Evidence
↓ Decrease
Statin therapy
Statins modestly reduce urine protein excretion in non-end-stage CKD beyond their cholesterol-lowering role. A 2023 Cochrane review found statins may lower 24-hour urine protein by about 0.47 g/day, with low-certainty evidence and substantial heterogeneity across trials. An older meta-analysis estimated a larger reduction of roughly 683 mg per day and a 22% drop in all-cause mortality.
MedicationModerate Evidence
↓ Decrease
GLP-1 receptor agonists (semaglutide, liraglutide, others)
These diabetes and weight-loss medications appear to reduce protein loss in the urine, especially in people with diabetic kidney disease or kidney transplant. In one kidney transplant cohort, protein-to-creatinine ratios and albumin-to-creatinine ratios fell by about 50% to 55% from baseline within months of starting therapy. Broader evidence is mostly observational and is driven more by preventing progression to macroalbuminuria than by reducing established heavy proteinuria.
MedicationModerate Evidence
↑ Increase
Bevacizumab and other VEGF pathway inhibitors
Bevacizumab causes drug-induced proteinuria that requires diagnostic testing via 24-hour urine collection per oncology guidelines. The proteinuria reflects real damage to the glomerular filter and can prompt dose holds or discontinuation if severe.
MedicationModerate Evidence
↑ Increase
Smoking
Tobacco use accelerates kidney injury and increases urinary protein loss through vascular damage to the glomerular filter. Quitting is considered standard advice for anyone with detected proteinuria.
LifestyleModerate Evidence

Frequently Asked Questions

References

27 studies
  1. Rydzewska-rosolowska a, Kakareko K, Naumnik B, Hryszko TKidney and Blood Pressure Research2019
  2. Mendelson L, Sanchorawala V, Connors L, Joshi T, Doros G, Pogrebinsky aKidney Medicine2022